Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 28 results:
Author Title Type [ Year] Filters: Author is Tsivgoulis, Georgios [Clear All Filters]
(2020).
Epidemiology of Patent Foramen Ovale in General Population and in Stroke Patients: A Narrative Review..
Front Neurol. 11, 281.
(2020). Neurological manifestations and implications of COVID-19 pandemic..
Ther Adv Neurol Disord. 13, 1756286420932036.
(2020). Optimization of risk stratification for anticoagulation-associated intracerebral hemorrhage: net risk estimation..
J Neurol. 267(4), 1053-1062.
(2020). The prognostic utility of ICH-score in anticoagulant related intracerebral hemorrhage..
J Neurol Sci. 409, 116628.
(2020). Safety and efficacy of dual antiplatelet pretreatment in patients with ischemic stroke treated with IV thrombolysis: A systematic review and meta-analysis..
Neurology. 94(7), e657-e666.
(2020).
(2020).
(2020). Anticoagulation After Stroke in Patients With Atrial Fibrillation..
Stroke. 50(8), 2093-2100.
(2019). Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options..
Auto Immun Highlights. 10(1), 7.
(2019). Comment on: "Oral Disease-Modifying Treatments for Relapsing Multiple Sclerosis: A Likelihood to Achieve No Evidence of Disease Activity or Harm Analysis"..
CNS Drugs. 33(3), 293-295.
(2019). Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke..
Eur Stroke J. 4(1), 55-64.
(2019). Functional Neurosonology Reveals Impaired Cerebrovascular Reactivity in Multiple Sclerosis..
J Neuroimaging. 29(5), 589-591.
(2019). Commentary on: Comparing the efficacy of disease-modifying therapies in multiple sclerosis..
Mult Scler Relat Disord. 21, 117-119.
(2018). Direct Oral Anticoagulants in Nonvalvular Atrial Fibrillation: Practical Considerations on the Choice of Agent and Dosing..
Cardiology. 140(2), 126-132.
(2018). Stroke Incidence and Outcomes in Northeastern Greece: The Evros Stroke Registry..
Stroke. 49(2), 288-295.
(2018). Integrins AV and B8 Gene Polymorphisms and Risk for Intracerebral Hemorrhage in Greek and Polish Populations..
Neuromolecular Med. 19(1), 69-80.
(2017).
(2016).
Correction: Observational study assessing demographic, economic and clinical factors associated with access and utilization of health care services of patients with multiple sclerosis under treatment with interferon beta-1b (EXTAVIA)..
PLoS One. 10(10), e0140308.
(2015). Effect of angiotensin-converting enzyme tag single nucleotide polymorphisms on the outcome of patients with traumatic brain injury..
Pharmacogenet Genomics. 25(10), 485-90.
(2015). The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis..
PLoS One. 10(3), e0116511.
(2015). The effect of disease-modifying therapies on brain atrophy in patients with clinically isolated syndrome: a systematic review and meta-analysis..
Ther Adv Neurol Disord. 8(5), 193-202.
(2015). AQP4 tag single nucleotide polymorphisms in patients with traumatic brain injury..
J Neurotrauma. 31(23), 1920-6.
(2014).
(2014). Mild cognitive impairment: effect of education on the verbal and nonverbal tasks performance decline..
Brain Behav. 2(5), 620-7.
(2012).